ATE272636T1 - Naphthyridine die den rezeptor il-4 und den faktor g-csf beeinflussen - Google Patents
Naphthyridine die den rezeptor il-4 und den faktor g-csf beeinflussenInfo
- Publication number
- ATE272636T1 ATE272636T1 AT97932142T AT97932142T ATE272636T1 AT E272636 T1 ATE272636 T1 AT E272636T1 AT 97932142 T AT97932142 T AT 97932142T AT 97932142 T AT97932142 T AT 97932142T AT E272636 T1 ATE272636 T1 AT E272636T1
- Authority
- AT
- Austria
- Prior art keywords
- naphthyridines
- receptor
- affect
- csf factor
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66918596A | 1996-06-20 | 1996-06-20 | |
PCT/US1997/009202 WO1997048368A2 (en) | 1996-06-20 | 1997-06-18 | Naphthyridines which affect il-4 and g-csf |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE272636T1 true ATE272636T1 (de) | 2004-08-15 |
Family
ID=24685412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97932142T ATE272636T1 (de) | 1996-06-20 | 1997-06-18 | Naphthyridine die den rezeptor il-4 und den faktor g-csf beeinflussen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0912571B1 (de) |
JP (2) | JP4181220B2 (de) |
CN (1) | CN1228090A (de) |
AT (1) | ATE272636T1 (de) |
AU (1) | AU3567397A (de) |
CA (1) | CA2258752C (de) |
DE (1) | DE69730137T2 (de) |
ES (1) | ES2225980T3 (de) |
WO (1) | WO1997048368A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2258752C (en) * | 1996-06-20 | 2006-08-15 | Schering Corporation | Naphthyridines which affect il-4 and g-csf |
KR20010102000A (ko) | 1999-02-08 | 2001-11-15 | 윌리암스 로저 에이 | 술파마토 히드록삼산 메탈로프로테아제 억제제 |
US6800646B1 (en) | 1999-02-08 | 2004-10-05 | Pharmacia Corporation | Sulfamato hydroxamic acid metalloprotease inhibitor |
NZ525439A (en) * | 2000-09-29 | 2004-11-26 | Topotarget Uk Ltd | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
EP1430894A4 (de) * | 2001-09-05 | 2007-12-12 | Eisai R&D Man Co Ltd | Lymphozyten-aktivierungshemmer und mittel zur behandlung von autoimmunkrankheiten |
MXPA04010555A (es) | 2002-04-25 | 2005-02-17 | Pharmacia Corp | Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa. |
RU2007113915A (ru) * | 2004-09-14 | 2008-10-27 | Новартис АГ (CH) | Способ получения 6, 8-замещенных производных 1, 7-нафтиридина реакцией производного 8-галоген-1, 7-нафтиридина с органическими производными борной кислоты и промежуточные соединения для этого способа |
DE102008019838A1 (de) * | 2008-04-19 | 2009-12-10 | Boehringer Ingelheim International Gmbh | Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2550575A1 (de) * | 1975-11-11 | 1977-05-12 | Scherico Ltd | Naphthyridine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
GB1545767A (en) * | 1976-06-30 | 1979-05-16 | Aspro Nicholas Ltd | Isoquinoline derivatives |
US4942163A (en) * | 1989-03-07 | 1990-07-17 | E. I. Du Pont De Nemours And Company | 1(2H)-isoquinolinones and 1-isoquinolineamines as cancer chemotherapeutic agents |
CA2258752C (en) * | 1996-06-20 | 2006-08-15 | Schering Corporation | Naphthyridines which affect il-4 and g-csf |
-
1997
- 1997-06-18 CA CA002258752A patent/CA2258752C/en not_active Expired - Fee Related
- 1997-06-18 AU AU35673/97A patent/AU3567397A/en not_active Abandoned
- 1997-06-18 WO PCT/US1997/009202 patent/WO1997048368A2/en active IP Right Grant
- 1997-06-18 EP EP97932142A patent/EP0912571B1/de not_active Expired - Lifetime
- 1997-06-18 CN CN97197310A patent/CN1228090A/zh active Pending
- 1997-06-18 JP JP50299898A patent/JP4181220B2/ja not_active Expired - Fee Related
- 1997-06-18 ES ES97932142T patent/ES2225980T3/es not_active Expired - Lifetime
- 1997-06-18 AT AT97932142T patent/ATE272636T1/de not_active IP Right Cessation
- 1997-06-18 DE DE69730137T patent/DE69730137T2/de not_active Expired - Lifetime
-
2008
- 2008-04-28 JP JP2008117917A patent/JP2008255119A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN1228090A (zh) | 1999-09-08 |
DE69730137T2 (de) | 2005-07-14 |
DE69730137D1 (de) | 2004-09-09 |
WO1997048368A2 (en) | 1997-12-24 |
EP0912571B1 (de) | 2004-08-04 |
JP2002501472A (ja) | 2002-01-15 |
EP0912571A2 (de) | 1999-05-06 |
CA2258752C (en) | 2006-08-15 |
WO1997048368A3 (en) | 1998-02-05 |
CA2258752A1 (en) | 1997-12-24 |
AU3567397A (en) | 1998-01-07 |
JP4181220B2 (ja) | 2008-11-12 |
ES2225980T3 (es) | 2005-03-16 |
JP2008255119A (ja) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL112778A0 (en) | Substituted heterocycles, their preparation and pharmaceutical compositions containing them | |
HK1027979A1 (en) | Indole derivatives and their use as mcp-1 antagonists | |
IL133988A0 (en) | Indole derivatives as mcp-1 receptor antagonists | |
MY112102A (en) | Therapeutic heterocycles. | |
KR100246065B1 (en) | Substituted 3-aminoquinuclidines | |
EP0709375A3 (de) | Therapeutisch wirksame Heterocyclen | |
ZA915727B (en) | Quinuclidine derivatives | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
ZA969621B (en) | Therapeutic compounds | |
GR3033528T3 (en) | Novel piperidine derivatives with paf antagonist activity | |
ZA961069B (en) | Heterocyclic derivatives | |
ATE201671T1 (de) | Chinolon und acridinon derivate zur behandlung der harninkontinenz | |
ATE272636T1 (de) | Naphthyridine die den rezeptor il-4 und den faktor g-csf beeinflussen | |
NZ330944A (en) | Peptide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |